D-0771-2022 Class II Terminated

Recalled by Preferred Pharmaceuticals, Inc. — Anaheim, CA

FDA drug recall D-0771-2022 was initiated by Preferred Pharmaceuticals, Inc. on Mar 24, 2022 and is designated Class II. Reason for recall: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. The recall status is terminated (terminated Nov 17, 2023). Affected quantity: 41 Tubes.

Recall Details

Product Type
Drugs
Report Date
Apr 20, 2022
Initiation Date
Mar 24, 2022
Termination Date
Nov 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
41 Tubes

Product Description

Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Preferred Pharmaceuticals, Inc., The Physican's Solution, Mfg: Teligent Pharma, Inc., NDC 68788-7406-03

Reason for Recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Distribution Pattern

Product distributed in California and Florida.

Code Information

Lot #: A1122P, G1421N, Exp. 1/1/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0771-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.